Exciting News: Pfizer and BioNTech’s Omicron KP.2-Adapted COVID-19 Vaccine Receives Positive EU Opinion and Awaits Approval
Pfizer and BioNTech’s Omicron KP.2-Adapted COVID-19 Vaccine Receives Positive EU Recommendation On September 21, 2024, Pfizer Inc. and BioNTech SE ...
